Pri-Med West - Primary Care CME/CE Conference & Expo

Anaheim, CA | May 5-7, 2022

Anaheim Convention Center

Evaluating the Latest Evidence in ASCVD Risk Reduction: Experts Tell All

Description

This clinically focused session will address many important questions regarding the management of elevated triglycerides with the goal of providing practical guidance to manage patients at high CV risk. The expert faculty will compare data on safety, tolerability, and the cardioprotective benefits of the various treatment strategies available.

Learning Objectives

Describe the causal association between triglycerides (TG), TG-rich lipoproteins (TRL), TRL remnants, and significant increased risk of major adverse cardiovascular events

Explain the role of omega-3 fatty acids, particularly icosapent ethyl, on reducing the risk of major adverse cardiovascular events in patients with hypertriglyceridemia

Screen, diagnose, and manage patients with hypertriglyceridemia who are at high risk of cardiovascular events based on professional society guidelines and recent large-scale randomized clinical trial evidence


Speakers

Karol E. Watson, MD, PhD

Karol E. Watson, MD, PhD, is a Professor of Medicine/Cardiology and a board-certified, fulltime cardiologist at the Geffen School of Medicine at UCLA. She holds the John C. Mazziotta Term Chair in Medicine and was honored to be named Cardiologist of ...

View Full Bio

Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC

Dr. Nathan Wong is a cardiovascular epidemiologist, specialist in preventive cardiology, and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine, with joint appointments in epidemio...

View Full Bio


Educational Partners

Medtelligence, Inc.

Commercial Supporters

Amarin Pharma Inc.